This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug Topics: What will be the likely impacts of this change that pharmacists will need to communicate with their patients? This schedule also helped dictate insurance coverage of those recommended vaccines.
She warned that changes in vaccine recommendations could impact insurance coverage, patient access, and ultimately public health, particularly for vulnerable populations like low-income children.
As benefits and patient eligibility to federal and state insurance programs continue to evolve, PAP programs are poised to take on even greater importance for vulnerable people seeking access to critical prescription medications in the US.
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54
Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.
June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regulus becomes Novartis’ indirect wholly owned subsidiary. Find out more The development follows an agreement in April 2025 in which Novartis signed an agreement to acquire Regulus and its oligonucleotide therapy, farabursen. Credit: JHVEPhoto/Shutterstock.
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.
Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick.
June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.
Robert Barrie July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook LEO calls Spevigo “the flagship dermatology product” of Boehringer Ingelheim. The deal is expected to close in the second half of 2025. Credit: JHVEPhoto via Shutterstock. Give your business an edge with our leading industry insights.
Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.
Manasi Vaidya June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook A panel at the 2025 BIO International Convention discuss the state of the European biotech funding ecosystem. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.
Abigail Beaney June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EHDS has come into force but it has not yet been fully rolled out, with EU member states still in discussions over how the legislation will work. One of the two panels on EHDS at HLTH Europe 2025. Image credit: Abigail Beaney / GlobalData.
GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.
Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CDK2 play a key role in tumour growth, with its dysregulation in cancer leading to uncontrolled cell proliferation via cell cycle progression. Give your business an edge with our leading industry insights.
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will add a suite of products designed for addiction treatment. Finalisation of the transaction hinges on approval during a general meeting scheduled for 14 July 2025, with plans set for completion the following day.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!
Robert Barrie June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Both Kisunla and Leqembi are both approved by the Medicines and Healthcare products Regulatory Agency (MHRA), meaning they will still be available privately. Give your business an edge with our leading industry insights.
GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The future Alzheimer’s disease treatment paradigm is anticipated to be combinatorial. The momentum in acquisition activity continued into 2025, with total deal value reaching $16.8 Credit: JLStock via Shutterstock.
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Credit: Viacheslav Lopatin/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Genomics CEO Professor Sir Peter Donnelly with Justin Ash, CEO of Spire Healthcare. Image credit: Genomics. Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent diseases.
Abigail Beaney June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The ‘space factory’ will likely be within a satellite, King explained at HLTH Europe. In February 2025, Auxilium’s 3D printer built eight implantable medical devices for peripheral nerve repair on the ISS in two hours.
Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Anne Cathrine Fleischer, vice president of Global Obesity Consumer Engagement and New Business Models at Novo Nordisk, announced the platform at HLTH Europe. Give your business an edge with our leading industry insights.
June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funding will support the development and commercialisation of RAS(ON) inhibitor to treat cancers. Credit: SmartPhotoLab/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Draig Therapeutics founders: L-R: John Atack, Ruth McKernan and Simon Ward. Credit: Draig Therapeutics/ GlobeNewswire. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Fluimucil IV is now available to patients across China as an essential hospital-based treatment for respiratory conditions. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The partnership will expand treatment options for mental health in the US. Preparations are underway to introduce Exxua into the US market swiftly, aiming for pharmacy and patient access by late 2025. Credit: Coco Ratta/Shutterstock.
June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Currently in Phase I clinical testing in China, the ADC is expected to enter clinical trials in the US in the third quarter of 2025. In January 2025, AbbVie and Simcere Zaiming entered an option-to-license agreement for the development of SIM0500.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new facility in Hungary will create 100 local jobs. Credit: SCHOTT Pharma. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.
Robert Barrie June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in Vor Bio opened 45% higher on 26 June following the announcement the day prior. Credit: ADragan via Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia. Credit: aipicte/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook PET scans play in an integral part in patients receiving anti-amyloid therapies. Credit: Utthapon wiratepsupon via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The research is supported by John Dimitri Research Foundation for Congenital Heart Disease and Big Hearts 2 Little Hearts. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content